Synergistic chemotherapy and phototherapy based on red blood cell biomimetic nanomaterials

J Control Release. 2022 Dec:352:146-162. doi: 10.1016/j.jconrel.2022.10.019. Epub 2022 Oct 19.

Abstract

Novel drug delivery systems (DDSs) have become the mainstay of research in targeted cancer therapy. By combining different therapeutic strategies, potential DDSs and synergistic treatment approaches are needed to effectively deal with evolving drug resistance and the adverse effects of cancer. Nowadays, developing and optimizing human cell-based DDSs has become a new research strategy. Among them, red blood cells can be used as DDSs as they significantly enhance the pharmacokinetics of the transported drug cargo. Phototherapy, as a novel adjuvant in cancer treatment, can be divided into photodynamic therapy and photothermal therapy. Phototherapy using erythropoietic nanocarriers to mimic the unique properties of erythrocytes and overcome the limitations of existing DDSs shows excellent prospects in clinical settings. This review provides an overview of the development of photosensitizers and research on bio-nano-delivery systems based on erythrocytes and erythrocyte membranes that are used in achieving synergistic outcomes during phototherapy/chemotherapy.

Keywords: Drug delivery system; Erythrocytes; Photosensitizers; Phototherapy; Red blood cells; Synergistic effect.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomimetics
  • Drug Delivery Systems
  • Erythrocyte Membrane
  • Humans
  • Nanoparticles* / therapeutic use
  • Nanostructures*
  • Neoplasms* / drug therapy
  • Phototherapy